One might assume patients presenting to an ED with sepsis are automatically admitted to the hospital. However, a presentation at the recent American Thoracic Society's annual international conference in San Diego revealed some surprising statistics and, perhaps, even more shocking patient results.
Based on treatment guidelines, emergency clinicians sometimes are hesitant to use IV tissue plasminogen activator (tPA) in stroke patients on anticoagulation therapy. Yet research discussed at the International Stroke Conference earlier this year indicates that being on anticoagulants should not prohibit tPA use in acute ischemic stroke patients, study authors determined.
Previous research has documented that wildfires, such as the one that killed more than 40 people and destroyed more than 5,000 homes in the wine country north of San Francisco last fall, can worsen respiratory conditions in some patients.
Allergan Inc. will pay $3.5 million to resolve allegations brought against it under the False Claims Act. The allegations surround Allergan’s LAP-BAND device, which is used by physicians to assist obese patients with weight reduction.
In March, the Centers for Medicare and Medicaid Services (CMS) announced a new initiative called “MyHealthEData,” designed to allow patients to control their own health data and make it portable from provider to provider. In late April, CMS announced a “Data Driven Patient Care Strategy” to advance that initiative.
The medical device company Alere Inc. will pay the United States $33.2 million to resolve allegations brought against it under the federal False Claims Act. The complaint alleged that Alere knowingly submitted false claims to federal and state healthcare programs for unreliable point-of-care diagnostic testing devices, according to a U.S. Justice Department press release.